Objective To compare the impact of three strategies for delivering a booster dose of adult-formulated tetanus-diphtheria-pertussis (Tdap) vaccine to adolescents in Australia. These comprise: (1) administering Tdap to: a one-year age cohort; (2) administering Tdap to the entire high school and to subsequent entrant cohorts (3) administering Tdap to the entire high school but without continuing to immunize entrant cohorts.
Introduction
Australia has seen large numbers of pertussis notifications in adolescents and adults over the past 10 to 15 years, as have some North American and European countries with longstanding high coverage for diphtheria-tetanus-pertussis (DTP) vaccines in childhood immunization programmes.
1-3 DTP vaccines have been in general use in Australia since the 1950s, [4] [5] [6] but because of concern about the possible adverse effects of the whole-cell pertussis component, 7 during the 1970s and 1980s DTP vaccine was frequently substituted with diphtheria-tetanus (DT) vaccine, and this led to a partially immunized Publication: Bulletin of the World Health Organization; Type: Research Article ID: BLT.11.086538 cohort. 8 Members of this cohort, which was also the last to not be eligible to receive the pre-school DTP booster added to the immunization schedule in 1994, 9 figured prominently in successive epidemics between 1993 and 2002. A similar cohort effect has been observed in Canada. 3 School outbreaks were also frequent at this time. 10 Acellular vaccines replaced the Australian-manufactured whole-cell vaccine for booster doses in 1997 and for all doses in 1999, and 95% coverage with three doses of this new vaccine (at 2, 4 and 6 months) by 2 years of age was attained within 4 years. 11 The availability of a well formulated triple vaccine with an acellular pertussis component (Boostrix [Tdap] , GlaxoSmithKline, Brentford, England) and the recognition that pertussis incidence in adolescents was increasing prompted the National Immunisation Programme to begin using Tdap on 1 January 2004 instead of the reduced antigen diphtheria-tetanus (Td) booster dose previously recommended at age 15 to 17
years. 12 Delivery of Tdap vaccine was primarily school-based, with limited doses also available in primary care.
Although several countries, including Canada, France, Germany and the United
States of America, have added an adolescent booster dose to their list of recommended immunizations, reports of the impact of adolescent pertussis vaccine programmes has been limited to early and/or regional data. [13] [14] [15] [16] [17] The aim of this study was to compare the long-term impact of the approaches used in Australia -vaccinating a one-year age cohort versus the entire high school, with and without continued immunization of high school entrants -in the context of known historical differences in pertussis epidemic cycles by region. 6 Our findings have implications for countries considering the introduction of Tdap boosters for children and adolescents 10 to 18 years of age.
Methods
We conducted a series of ecologic analyses of trends in pertussis notifications by age group, using relative incidence by time period, epidemic cycle and estimated vaccine coverage, to compare notification rates in relevant age cohorts. Data sources and methods of estimation for these analyses are described in the following sections.
Vaccine coverage
Immunization programme managers from each Australian state and territory provided coverage data from school-based delivery programmes for the period between January Cases can be notified on clinical grounds alone if they report having had a coughing illness lasting 2 or more weeks and paroxysms of coughing, inspiratory whoop or posttussive vomiting. 18 However, over the past decade cases without laboratory evidence have become increasingly rare. We calculated notification rates for each age group and time period using average annual Australian Bureau of Statistics population estimates. 19 We used the ratio of notification rates between epidemiologically relevant time periods (incidence rate ratios [IRRs]) as the measure for comparison of programme impact, and we calculated their 95% confidence intervals (CIs) using a Poisson distribution.
With respect to programme delivery comparisons, we calculated incidence rate ratios (IRRs) using regional groupings based on differing programme delivery characteristics ( (Table 2) .
Results

Vaccination coverage
Overall, an estimated 1 066 000 of an estimated 1 650 000 eligible students aged 12 to (Table 1) . However, estimated coverage within regions remained the same from year to year. In New South Wales and Western Australia, where the entire high school population was vaccinated within a single calendar year, higher coverage was obtained among younger students in the lower high school grades.
Pertussis notification before and after Tdap
By age group Western Australia, where students entering high school continued to be vaccinated year after year after the entire high school population was vaccinated, notification rates also decreased rapidly but remained low to the end of 2009.
By cohort immunization status
Given the wide variation in programme roll-out by age group and timing of epidemic peaks in notifications across regions, we used notification rates in immunized and unimmunized age groups, as defined in the methods section, to generate IRRs for each region. Table 4 In Queensland, incidence did not differ among immunized and unimmunized cohorts but was significantly lower in both groups after the Tdap vaccination programme was implemented.
Notification trends in young infants
The same regional programme delivery groupings were used to compare trends over time in pertussis notification rates among infants less than 6 months of age (Table 5 noted that supporting data on cost-effectiveness for programmes targeting adolescents were lacking and that data on impact on infant disease were particularly relevant. 21 Countries that have added an adolescent booster dose to their schedules since the 2002 recommendation include Canada, France Germany, New Zealand and the United States. 22 Timing of programme commencement has varied widely and data on disease reduction in the targeted age group are lacking. In this national evaluation, we have taken account of variations in vaccine delivery, programme implementation and pertussis epidemic cycles 24, 25 Similarly, lower coverage in older high school students was observed in the Australian meningococcal C conjugate vaccine catchup programme. 23 This is probably because of more frequent absences from school among older students and lower school retention rates (81% for grades [10] [11] [12] 26 and is likely to be applicable in comparable developed country settings.
The use of pertussis notification data to measure impact from an adolescent Tdap programme is confounded by interannual and epidemic variations in pertussis activity, which we took into account in our analysis, as well as by changes in diagnostic practice. 16 We were unable to estimate vaccine effectiveness in the current study because individual level data on vaccination status is lacking.
In Western Australia, the notification rate in the unimmunized cohort was nearly However, more detailed analysis showed that grade 10 students, who were being vaccinated during the epidemic, had a higher IRR than the rest of the immunized cohort.
A key question is whether adolescent pertussis immunization programmes have any impact on pertussis transmission among young, unimmunized infants. In our data, the pertussis notification rate among infants younger than 6 months following the initiation of Although limited by its ecologic design, our analysis provides some evidence that a pertussis vaccination catch-up component has an impact on herd immunity and on the incidence of disease among infants. Catch-up programmes can rapidly reduce pertussis incidence across a broad range of ages and ongoing immunization of children entering adolescence may be important for maintaining this in the long term. The consistently higher notification rates in younger adolescents also suggest that the programme should target younger age groups. Targeting a programme to younger people will have follow-up implications for countries considering cocooning recommendations for new parents, which must factor in the waning of antibody levels between adolescence and pregnancy.
The most recent data suggest that antibodies levels have dropped substantially by the tenth year after immunization. 28 In conclusion, data from Australia demonstrate that school-based adolescent pertussis vaccination programmes can achieve high coverage relatively rapidly and have a demonstrable impact on the incidence of pertussis, as measured by case notifications. Our experience suggests that, in the context of school-based delivery, implementing a broadly based vaccination programme is more beneficial than introducing the vaccine in a single school year, but that it is necessary to immunize children entering high school on an ongoing basis. This is particularly important if it is shown that broad-based catch-up immunization of adolescents effectively decreases the incidence of severe disease in unimmunized infants.
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